정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1080 | Recruiting | Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia | Viral Pneumonia | Drug: Melphalan Other: Standard of care |
Phase 2 | Federal State Budgetary Institution, Pulmonology Scientific Research Institute, Medsi Clinic #1, Moscow, Moscow State University of Medicine and Dentistry | OTHER_GOV | 60 | All | 18 Years | Kirill Zykov, Moscow, Russian Federation Clinical hospital, Moscow, Russian Federation |
| 1079 | Active, not recruiting | LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) | Acute Kidney Injury | Drug: LSALT peptide Drug: Placebo |
Phase 2 | Arch Biopartners Inc. | INDUSTRY | 60 | All | 45 Years ~ 80 Years | VA San Diego Healthcare System, San Diego, California, United States Broward Health Medical Center, Fort Lauderdale, Florida, United States LSU Health Shreveport, Shreveport, Louisiana, United States University of Calgary - Foothills Medical Centre, Calgary, Alberta, Canada University of Calgary - Peter Lougheed Centre, Calgary, Alberta, Canada Ankara City Hospital, Ankara, Turkey Istanbul University Cerrahpasa, Istanbul, Turkey |
| 1078 | Recruiting | LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A | Central Nervous System Lymphoma | Drug: Voraxaze Drug: Methotrexate Drug: Rituximab Drug: leucovorin Drug: Glucarpidase |
Early Phase 1 | Memorial Sloan Kettering Cancer Center, University of Alabama at Birmingham | OTHER | 44 | All | 18 Years | University of Alabama at Birmingham, Birmingham, Alabama, United States Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States Memorial Sloan Kettering Commack, Commack, New York, United States Memorial Sloan Kettering Westchester, Harrison, New York, United States Memorial Sloan Kettering Cancer Center, New York, New York, United States Memorial Sloan Kettering Nassau, Uniondale, New York, United States |
| 1077 | Recruiting | LYT-100 in Post-acute COVID-19 Respiratory Disease | Covid19 | Drug: LYT-100 Other: Placebo |
Phase 2 | PureTech, Clinipace Worldwide, Novotech (Australia) Pty Limited | INDUSTRY | 168 | All | 18 Years ~ 80 Years | University of Alabama at Birmingham, Birmingham, Alabama, United States North Alabama Medical Center, Florence, Alabama, United States University of Southern California - Keck School of Medicine, Los Angeles, California, United States Broward Research Center, Aventura, Florida, United States Central Florida Pulmonary Group, Orlando, Florida, United States Tampa General Hospital, Tampa, Florida, United States Southeastern Research Center, Winston-Salem, North Carolina, United States University of Pittsburg Medical Center, Pittsburgh, Pennsylvania, United States Site Coordinator, Austin, Texas, United States Frostwood Family Medicine, Houston, Texas, United States The University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, United States PMSI Republican Clinical Hospital "T. Mosneaga", Chisinau, Moldova, Republic of University of the Philippines Manila - Philippine General Hospital (PGH), Manila, Philippines Quirino Memorial Medical Center (QMMC), Quezon City, Philippines Institutul de Pneumoftiziologie "Marius Nasta" ("Marius Nasta" Pneumoftiziology Institute), Bucharest, Romania National Institute for Infectious Diseases "Prof. Dr. Matei Bal?" (Arensia Eploratory Medicine), Bucharest, Romania Spitalul Clinic De Pneumoftiziologie "Leon Daniello" Cluj-Napoca, Cluj-Napoca, Romania Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr. Victor Babes Craiova, Craiova, Romania Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr. Victor Babes - Timisoara, Timi?oara, Romania Medical Center of Limited Liability Company "Harmoniya krasy", Kiev, Ukraine Guy's and St Thomas' NHS Foundation Trust - St Thomas' Hospital, London, United Kingdom St George's University Hospitals NHS Foundation Trust - St George's Hospital, London, United Kingdom |
| 1076 | Not yet recruiting | MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis | Rheumatoid Arthritis | Biological: MabionCD20 (candidate biosimilar to rituximab) Biological: MabThera® Biological: Rituxan® |
Phase 3 | Mabion SA, Parexel | INDUSTRY | 280 | All | 18 Years ~ 80 Years | |
| 1075 | Recruiting | Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso | Malaria | Drug: Artemether-lumefantrine (AL) Drug: Pyronaridine-artesunate (PA) |
Phase 3 | Liverpool School of Tropical Medicine, London School of Hygiene and Tropical Medicine, Kenya Medical Research Institute, Groupe de Recherche Action en Sante, Centres for Disease Control and Prevention, Kenya., Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention | OTHER | 142 | All | 6 Months ~ 100 Years | Ouagadougou Hospitals, Ouagadougou, Burkina Faso Kisumu County Referral Hospital, Kisumu, Kenya |
| 1074 | Recruiting | Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy | Severe covid19 | Combination Product: autologous activated platelet-rich plasma Drug: Avigan |
Phase 2 | Hayandra Peduli Foundation, Koja Regional Public Hospital | OTHER | 30 | All | 18 Years ~ 65 Years | Koja Regional Public Hospital, Jakarta, DKI Jakarta, Indonesia |
